Histomorphometric and immunohistochemical evaluation of beta-tricalcium phosphate of different particles dimensions in maxillary sinus floor elevation: a randomized clinical study

Not Applicable

• Conditions: Stomatognathic diseases; Maxillary sinus; Bone substitutes; Bone resorption; A04.531.621.578; D25.130.325; C05.116.264

• Registration Number: RBR-63c3gn
• Lead Sponsor: Faculdade de Odontologia de Araçatuba

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-06-03
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Data analysis completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Atrophic posterior maxillary region and residual bone height less than 5 mm requiring bone augmentation rehabilition with dental implants.

Exclusion Criteria

smokers, patients with uncontrolled systematic disease, maxillary sinus diseases, and patients with an inadequate amount of bone in the mandible symphysis where the autogenous bone graft was harvested.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
It is expected to find an increase in the alveolar bone height, assessed by means of computed tomography and histomorphometry, from the observation of neoformed bone tissue on the remaining border.

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes are not expected